Adalimumab-induced interstitial pneumonia in patients with inflammatory bowel disease

Respir Med Res. 2020 Nov;78:100790. doi: 10.1016/j.resmer.2020.100790. Epub 2020 Sep 17.
No abstract available

Keywords: Adalimumab; Anti-tumor necrosis factor; Inflammatory bowel disease; Interstitial lung disease; Pulmonary sarcoidosis-like.

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Humans
  • Inflammatory Bowel Diseases* / complications
  • Inflammatory Bowel Diseases* / drug therapy
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / diagnostic imaging

Substances

  • Adalimumab